ConductScience.org, home

Paper745017

Recent observations on the clinical pharmacology of (-)deprenyl.

Stern GM and 2 others. J Neural Transm, 1978. Cited by 59 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Recent observations on the clinical pharmacology of (-)deprenyl. Papers, record 745017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/745017

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent observations on the clinical pharmacology of (-)deprenyl.
PubMed
Journal
J Neural Transm
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3.29
iCite
Revised in PubMed
2019-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stern GMG M
2Lees AJA J
3Sandler MM

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
PhenethylaminesMajor topic
SelegilineMajor topic
Adult
Aged
Blood Pressure
Drug Therapy, Combination
Heart Rate
Humans
Levodopa
Middle Aged
Time Factors
Tyramine

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,943,186Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.Psychopharmacologia1970https://conductscience.org/library/papers/4943186PubMed
271,602Deprenyl in Parkinson's disease.Lancet1977https://conductscience.org/library/papers/71602PubMed
365,560Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study.Lancet1977https://conductscience.org/library/papers/65560PubMed
4656,120Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.Biochem Pharmacol1978https://conductscience.org/library/papers/656120PubMed
596,466Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/96466PubMed
64,403,272The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle.Ergeb Physiol1972https://conductscience.org/library/papers/4403272PubMed
7728,327Deprenyl is metabolized to methamphetamine and amphetamine in man.Br J Clin Pharmacol1978https://conductscience.org/library/papers/728327PubMed
81,172,524The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.J Neural Transm1975https://conductscience.org/library/papers/1172524PubMed
94,155,234The clinical physiology of side effects in long-term L-DOPA therapy.Adv Neurol1974https://conductscience.org/library/papers/4155234PubMed
1011,422,885Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.Psychiatry Clin Neurosci2001https://conductscience.org/library/papers/11422885PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
34,784,871How to Optimize the Effectiveness and Safety of Parkinson's Disease Therapy? - A Systematic Review of Drugs Interactions with Food and Dietary Supplements.Curr Neuropharmacol2022https://conductscience.org/library/papers/34784871PubMed
20,614,454Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20614454PubMed
9,673,855Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.Drug Saf1998https://conductscience.org/library/papers/9673855PubMed
9,067,124Drug-induced sleep disturbances. Focus on nonpsychotropic medications.Drug Saf1997https://conductscience.org/library/papers/9067124PubMed
7,264,627Treatment of Parkinson's disease: problems with a progressing disease.J Neural Transm1981https://conductscience.org/library/papers/7264627PubMed
6,809,891The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.J Neural Transm1982https://conductscience.org/library/papers/6809891PubMed
6,766,730Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6766730PubMed
3,929,314Tyramine pressor sensitivity changes during deprenyl treatment.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3929314PubMed
2,436,247Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2436247PubMed
2,413,370The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/2413370PubMed
2,112,994Selegiline and Parkinson's disease. Protective and symptomatic considerations.Drugs1990https://conductscience.org/library/papers/2112994PubMed
745,013Absence of "cheese effect" during deprenyl therapy: some recent studies.J Neural Transm1978https://conductscience.org/library/papers/745013PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/745017

GET https://conductscience.org/api/papers/v1/745017/authors